The Percentage of [−2]Pro–Prostate-Specific Antigen and the Prostate Health Index Outperform Prostate-Specific Antigen and the Percentage of Free Prostate-Specific Antigen in the Detection of Clinically Significant Prostate Cancer and Can Be Used as Reflex Tests

Context.—: There is a need to avoid the overdiagnosis of prostate cancer (PCa) and to find more specific biomarkers. Objective.—: To evaluate the clinical utility of [-2]pro-prostate-specific antigen ([-2]proPSA) derivatives in detecting clinically significant PCa (csPCa) and to compare it with pros...

ver descrição completa

Detalhes bibliográficos
Autor principal: Garrido, MM (author)
Outros Autores: Marta, JC (author), Bernardino, RM (author), Guerra, J (author), Fernandes, F (author), Pereira, MH (author), Ribeiro, R (author), Holdenrieder, S (author), Pinheiro, LC (author), Guimarães, JT (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
Prostate-Specific Antigen
Prostate Cancer
HSJ PAT CLIN
HSJ ANPAT
Texto completo:http://hdl.handle.net/10400.17/4104
País:Portugal
Oai:oai:repositorio.chlc.min-saude.pt:10400.17/4104

Texto Completo

http://hdl.handle.net/10400.17/4104

Registros relacionados